Literature DB >> 24291671

Novel Vitamin K analogs suppress seizures in zebrafish and mouse models of epilepsy.

J J Rahn1, J E Bestman1, B J Josey1, E S Inks1, K D Stackley1, C E Rogers1, C J Chou2, S S L Chan3.   

Abstract

Epilepsy is a debilitating disease affecting 1-2% of the world's population. Despite this high prevalence, 30% of patients suffering from epilepsy are not successfully managed by current medication suggesting a critical need for new anti-epileptic drugs (AEDs). In an effort to discover new therapeutics for the management of epilepsy, we began our study by screening drugs that, like some currently used AEDs, inhibit histone deacetylases (HDACs) using a well-established larval zebrafish model. In this model, 7-day post fertilization (dpf) larvae are treated with the widely used seizure-inducing compound pentylenetetrazol (PTZ) which stimulates a rapid increase in swimming behavior previously determined to be a measurable manifestation of seizures. In our first screen, we tested a number of different HDAC inhibitors and found that one, 2-benzamido-1 4-naphthoquinone (NQN1), significantly decreased swim activity to levels equal to that of valproic acid, 2-n-propylpentanoic acid (VPA). We continued to screen structurally related compounds including Vitamin K3 (VK3) and a number of novel Vitamin K (VK) analogs. We found that VK3 was a robust inhibitor of the PTZ-induced swim activity, as were several of our novel compounds. Three of these compounds were subsequently tested on mouse seizure models at the National Institute of Neurological Disorders and Stroke (NINDS) Anticonvulsant Screening Program. Compound 2h reduced seizures particularly well in the minimal clonic seizure (6Hz) and corneal-kindled mouse models of epilepsy, with no observable toxicity. As VK3 affects mitochondrial function, we tested the effects of our compounds on mitochondrial respiration and ATP production in a mouse hippocampal cell line. We demonstrate that these compounds affect ATP metabolism and increase total cellular ATP. Our data indicate the potential utility of these and other VK analogs for the prevention of seizures and suggest the potential mechanism for this protection may lie in the ability of these compounds to affect energy production.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid; 2-benzamido-1,4-naphthoquinone; 2-propylpentane hydroxamic acid; 2h; 2j; 2q; 3n; AED; ATP; ATP metabolism; DMEM; DMSO; Dulbecco’s Modified Eagle’s Medium; ECAR; ETC; FCCP; HDAC; HEPES; MB; NINDS; NQN1; National Institute of Neurological Disorders and Stroke; OCR; PTZ; ROS; SAHA; SEM; SOD2; VK; VK analog modified by the addition of a benzyl amine group to the 2′ position of the 1,4-naphthoquinone motif of VK; VK analog. It is a modification of analog 2j with the addition of chlorine at the meta position of the added benzene ring; VK analog. It is a modification of analog 2j, with the addition of a terminal alkyne to the added benzene; VK analog. It was created by replacing the central methylene group of analog 2j with a carbonyl group; VK3; VPA; VPHA; Vitamin K; Vitamin K3; adenosine triphosphate; anti-epileptic drug; days post fertilization; dimethyl sulfoxide; dpf; electron transport chain; epilepsy; extracellular acidification rate; histone deacetylase; methylene blue; mitochondria; oxygen consumption rate; pentylenetetrazol; reactive oxygen species; respiration; standard error of the mean; suberoylanilide hydroxamic acid; superoxide dismutase; trifluorocarbonylcyanide phenylhydrazone; valproic acid, 2-n-propylpentanoic acid; zebrafish

Mesh:

Substances:

Year:  2013        PMID: 24291671      PMCID: PMC3903788          DOI: 10.1016/j.neuroscience.2013.11.040

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  51 in total

1.  A novel class of small molecule inhibitors of HDAC6.

Authors:  Elizabeth S Inks; Benjamin J Josey; Sean R Jesinkey; C James Chou
Journal:  ACS Chem Biol       Date:  2011-11-11       Impact factor: 5.100

2.  Designing zebrafish chemical screens.

Authors:  Randall T Peterson; Mark C Fishman
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

Review 3.  Teratogenicity of sodium valproate.

Authors:  Rachel Alsdorf; Diego F Wyszynski
Journal:  Expert Opin Drug Saf       Date:  2005-03       Impact factor: 4.250

4.  Methylene blue prevents methylmalonate-induced seizures and oxidative damage in rat striatum.

Authors:  Ana Flávia Furian; Michele Rechia Fighera; Mauro Schneider Oliveira; Ana Paula de Oliveira Ferreira; Natália Gindri Fiorenza; Jociane de Carvalho Myskiw; João Carlos Petry; Rafael Correa Coelho; Carlos Fernando Mello; Luiz Fernando Freire Royes
Journal:  Neurochem Int       Date:  2006-09-11       Impact factor: 3.921

Review 5.  Perspectives of zebrafish models of epilepsy: what, how and where next?

Authors:  Adam Michael Stewart; Daniel Desmond; Evan Kyzar; Siddharth Gaikwad; Andrew Roth; Russell Riehl; Christopher Collins; Louis Monnig; Jeremy Green; Allan V Kalueff
Journal:  Brain Res Bull       Date:  2011-12-06       Impact factor: 4.077

6.  Anticonvulsant activity of bisabolene sesquiterpenoids of Curcuma longa in zebrafish and mouse seizure models.

Authors:  Adriana Monserrath Orellana-Paucar; Ann-Sophie K Serruys; Tatiana Afrikanova; Jan Maes; Wim De Borggraeve; Jo Alen; Fabián León-Tamariz; Isabel María Wilches-Arizábala; Alexander D Crawford; Peter A M de Witte; Camila V Esguerra
Journal:  Epilepsy Behav       Date:  2012-04-05       Impact factor: 2.937

7.  Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice.

Authors:  Suzanne L Hansen; Bonnie B Sperling; Connie Sánchez
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-01       Impact factor: 5.067

8.  Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.

Authors:  Pierre Tessier; David V Smil; Amal Wahhab; Silvana Leit; Jubrail Rahil; Zuomei Li; Robert Déziel; Jeffrey M Besterman
Journal:  Bioorg Med Chem Lett       Date:  2009-08-07       Impact factor: 2.823

Review 9.  Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 10.  Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.

Authors:  J Pelgrims; F De Vos; J Van den Brande; D Schrijvers; A Prové; J B Vermorken
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

View more
  12 in total

Review 1.  Inherited mitochondrial genomic instability and chemical exposures.

Authors:  Sherine S L Chan
Journal:  Toxicology       Date:  2017-07-26       Impact factor: 4.221

Review 2.  Advancements in zebrafish applications for 21st century toxicology.

Authors:  Gloria R Garcia; Pamela D Noyes; Robert L Tanguay
Journal:  Pharmacol Ther       Date:  2016-03-22       Impact factor: 12.310

Review 3.  Zebrafish Larvae Behavior Models as a Tool for Drug Screenings and Pre-Clinical Trials: A Review.

Authors:  João Gabriel Santos Rosa; Carla Lima; Monica Lopes-Ferreira
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

4.  Discovery of the First Vitamin K Analogue as a Potential Treatment of Pharmacoresistant Seizures.

Authors:  Xiaoyang Li; Richard A Himes; Lyndsey C Prosser; Charleston F Christie; Emma Watt; Sharon F Edwards; Cameron S Metcalf; Peter J West; Karen S Wilcox; Sherine S L Chan; C James Chou
Journal:  J Med Chem       Date:  2020-05-22       Impact factor: 7.446

5.  Multigenerational consequences of early-life cannabinoid exposure in zebrafish.

Authors:  Dennis R Carty; Zachary S Miller; Cammi Thornton; Zacharias Pandelides; Marisa L Kutchma; Kristine L Willett
Journal:  Toxicol Appl Pharmacol       Date:  2018-12-27       Impact factor: 4.219

6.  Amide linked redox-active naphthoquinones for the treatment of mitochondrial dysfunction.

Authors:  Krystel L Woolley; Monila Nadikudi; Mitra N Koupaei; Monika Corban; Paul McCartney; Alex C Bissember; Trevor W Lewis; Nuri Gueven; Jason A Smith
Journal:  Medchemcomm       Date:  2019-01-16       Impact factor: 3.597

7.  PPM-18, an Analog of Vitamin K, Induces Autophagy and Apoptosis in Bladder Cancer Cells Through ROS and AMPK Signaling Pathways.

Authors:  Huiai Lu; Chunlei Mei; Luhao Yang; Junyan Zheng; Junwei Tong; Fengsen Duan; Huageng Liang; Ling Hong
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

Review 8.  Zebrafish models in translational research: tipping the scales toward advancements in human health.

Authors:  Jennifer B Phillips; Monte Westerfield
Journal:  Dis Model Mech       Date:  2014-07       Impact factor: 5.758

9.  QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics.

Authors:  Paul G O'Reilly; Qing Wen; Peter Bankhead; Philip D Dunne; Darragh G McArt; Suzanne McPherson; Peter W Hamilton; Ken I Mills; Shu-Dong Zhang
Journal:  BMC Bioinformatics       Date:  2016-05-04       Impact factor: 3.169

10.  A zebrafish-centric approach to antiepileptic drug development.

Authors:  Scott C Baraban
Journal:  Dis Model Mech       Date:  2021-07-07       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.